MILK: A Mobile, Semi-automated Text Message-based Intervention to Prevent Perceived Low or Insufficient Milk Supply

Sponsor
University of Pittsburgh (Other)
Overall Status
Completed
CT.gov ID
NCT02724969
Collaborator
National Institute of Nursing Research (NINR) (NIH)
250
1
2
27
9.2

Study Details

Study Description

Brief Summary

The purpose of this pilot randomized trial is to determine the effectiveness, feasibility, and acceptability of a mobile, semi-automated text message-based intervention (MILK) to prevent perceived low or insufficient milk supply (PIM) among mothers without prior breastfeeding experience. PIM is the leading cause of premature breastfeeding cessation, and prior work shows that it is often rooted in low breastfeeding self-efficacy and misconceptions about lactation physiology and trajectory. The MILK intervention is designed to address PIM, as well as other common breastfeeding problems via semi-automated text messages of prenatal and postpartum breastfeeding education and support. Messages are time-sensitive (e.g., specific to gestational age, time since delivery) and based on the Breastfeeding Self-Efficacy (Social Cognitive) Theory; they are also modeled from pilot work that investigated how first-time mothers view, manage and describe breastfeeding problems. Messages were vetted with clinical lactation experts, as well as pregnant and postpartum women with no other children.

The MILK intervention will be trialed against a control intervention group, who will receive general perinatal education through the national Text4Baby system. The investigators will recruit approximately 186 healthy, pregnant women at 13-25 weeks gestation from Magee Women's Hospital clinics and outpatient sites. Women will be randomized via computer-generated simple randomization to the experimental or control intervention. Both groups will receive text messages 3-5 times per week from week 25 of pregnancy through week 8 postpartum. Measured outcomes of interest will include perceived breast milk supply, breastfeeding confidence, maternal anxiety, breastfeeding exclusivity, and breastfeeding duration. Data will be collected at baseline (13-25 gestational weeks), 34-36 gestational weeks, and at 1, 2, 4, and 8 weeks postpartum via online survey or telephone call. To assess the potential longer-term impact of the intervention, breastfeeding continuation and exclusivity will be reassessed via telephone at 6 months postpartum. Between group and group x time differences in outcome measures will be examined graphically and via linear mixed modeling. To inform modifications to MILK, telephone interviews will be conducted with a subset of participants in each group to assess and compare intervention use, burdens and challenges, and suggested alterations (8 weeks).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: MILK or Text4Baby text message intervention
N/A

Detailed Description

The purpose of the MILK Trial is to examine and compare the effectiveness, feasibility, and acceptability of a semi-automated, text-based, theory-driven intervention ("MILK" intervention) to prevent perceived insufficient milk and its potential inter-related sequelae, including maternal anxiety and early breastfeeding cessation, among mothers without breastfeeding experience who intend to exclusively or nearly exclusively breastfeed.

Specifically, the investigators will:
  1. Determine the effect of the MILK intervention on perceived insufficient milk supply (PIM) and related maternal psychological and behavioral sequelae.

Compared to the control intervention group ("Text4Baby"), the investigators hypothesize that MILK participants will have a perception of greater breast milk volume/supply, higher self-reported breastfeeding confidence, lower anxiety scores, and longer duration of exclusive breastfeeding.

  1. Assess the feasibility of a semi-automated text-based PIM intervention (MILK) for mothers.

The investigators will compare characteristics of women who are and who are not eligible for, chose to participate in, and complete this randomized pilot intervention study. The investigators will also conduct post-study individual interviews with mothers to determine how the interventions were used and perceived (e.g., burden, challenges).

Study Design

Study Type:
Interventional
Actual Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Care Provider, Outcomes Assessor)
Masking Description:
Lactation consultant providing assistance has no knowledge of group assignment. Statistician completing final analysis of data will be blinded to group assignment.
Primary Purpose:
Prevention
Official Title:
A Mobile, Semi-automated Text Message-based Intervention to Prevent Perceived Low or Insufficient Milk Supply
Actual Study Start Date :
Feb 9, 2017
Actual Primary Completion Date :
Jan 4, 2019
Actual Study Completion Date :
May 13, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: MILK intervention group

Semi-automated text messages sent to participants' cellular phones 3-5 times per week beginning Week 25 of pregnancy, through 8 weeks postpartum, specific to breastfeeding support and prevention of perceived insufficient milk supply.

Behavioral: MILK or Text4Baby text message intervention
MILK text message intervention encompasses prenatal and postpartum breastfeeding support and education text messages. Text4Baby text message intervention encompasses prenatal and postpartum text messages about pregnancy, infant care, and postpartum issues.

Active Comparator: Text4Baby control intervention group

Text4Baby automated texts sent to participants' cellular phones 3-5 times per week from Week 25 of pregnancy through the postpartum period from the national Text4Baby system. Messages provide general prenatal and postpartum support, including breastfeeding.

Behavioral: MILK or Text4Baby text message intervention
MILK text message intervention encompasses prenatal and postpartum breastfeeding support and education text messages. Text4Baby text message intervention encompasses prenatal and postpartum text messages about pregnancy, infant care, and postpartum issues.

Outcome Measures

Primary Outcome Measures

  1. Perception of milk supply [8 weeks postpartum]

    Assessed via the H & H Lactation Scale (21-item Likert scale)

Secondary Outcome Measures

  1. Breastfeeding self-efficacy [8 weeks postpartum]

    assessed via 14-item Breastfeeding Self-Efficacy Scale (Likert scale)

  2. Maternal anxiety [8 weeks postpartum]

    Assessed via Likert scale (8-item combined Emotional Distress-Anxiety scale and Perceived Stress Scale)

  3. Breastfeeding continuation [8 weeks postpartum]

    whether mom is doing any breastfeeding; assessed via questionnaire

  4. Breastfeeding exclusivity [8 weeks postpartum]

    whether mom is feeding 100% breast milk; assessed via questionnaire

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
Pregnant women who:
  1. are ≥ 18 years;

  2. are between 13-25 gestational weeks;

  3. have no prior breastfeeding experience or other living biological children;

  4. have a personal cell phone with internet access and an unlimited text message plan; and

  5. intend to exclusively, or nearly exclusively breastfeed (<2 ounces of artificial milk per day) for at least 2 months postpartum; (6) plan to deliver their infant at MWH.

Exclusion Criteria:
  1. Maternal, fetal, or neonatal conditions or complications with the potential to physiologically compromise breastfeeding or milk supply (e.g., history of breast reduction surgery, infant cardiac defects, postpartum infant ventilator dependence);

  2. current gestation of ≥ 1 fetus;

  3. contraindications to breastfeeding as specified by the American Academy of Pediatrics (e.g., HIV+ status).

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pittsburgh Pittsburgh Pennsylvania United States 15261

Sponsors and Collaborators

  • University of Pittsburgh
  • National Institute of Nursing Research (NINR)

Investigators

  • Principal Investigator: Jill Demirci, PhD, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jill R. Demirci, PhD, RN, IBCLC, Assistant Professor, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT02724969
Other Study ID Numbers:
  • PRO16020007
  • 5R00NR015106
First Posted:
Mar 31, 2016
Last Update Posted:
Sep 9, 2019
Last Verified:
Sep 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jill R. Demirci, PhD, RN, IBCLC, Assistant Professor, University of Pittsburgh

Study Results

No Results Posted as of Sep 9, 2019